πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

Showing page 101 of 857 Β· Phase 3 first, then by program name

  1. Lifitegrast

    Takeda

    Keratoconjunctivitis Sicca

    phase 3 small molecule completed

    1 trial

  2. Ligelizumab

    Novartis Pharmaceuticals

    Chronic Spontaneous Urticaria

    phase 3 mab completed

    1 trial

  3. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Functional Constipation

    phase 3 small molecule completed

    3 trials

  4. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Chronic Idiopathic Constipation

    phase 3 small molecule completed

    1 trial

  5. Linaclotide

    IRONWOOD PHARMACEUTICALS INC

    Chronic Constipation

    phase 3 small molecule completed

    1 trial

  6. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Chronic Constipation

    phase 3 small molecule completed

    2 trials

  7. Linaclotide 290 micrograms

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome Characterized by Constipation

    phase 3 small molecule completed

    1 trial

  8. Linaclotide or Matching Placebo

    IRONWOOD PHARMACEUTICALS INC

    Irritable Bowel Syndrome With Constipation

    phase 3 small molecule completed

    1 trial

  9. Linagliptin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    3 trials

  10. Linvoseltamab

    Regeneron UK Limited

    Relapsed Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    2 trials

  11. Linvoseltamab

    Regeneron UK Limited

    High Risk Smoldering Multiple Myeloma (HR-SMM)

    phase 3 small molecule active

    1 trial

  12. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma

    phase 3 small molecule active

    6 trials

  13. Linvoseltamab

    Regeneron UK Limited

    Multiple Myeloma (MM)

    phase 3 small molecule active

    1 trial

  14. Linvoseltamab

    Regeneron UK Limited

    Relapsed and/or Refractory Multiple Myeloma (RRMM)

    phase 3 small molecule active

    1 trial

  15. Lipid-lowing Tea

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperlipidemia

    phase 3 small molecule active

    1 trial

  16. Liposomal Amphotericin B (LAmB)

    Duke University

    Talaromycosis

    phase 3 small molecule active

    1 trial

  17. Liposomal Ciclosporin A, Liposomal Ciclosporin A

    Zambon SpA

    Bronchiolitis Obliterans Syndrome in Patients post Single or post Double Lung Transplantation

    phase 3 small molecule active

    1 trial

  18. Liposomal bupivacaine

    Pacira Ireland Limited

    Surgery

    phase 3 small molecule completed

    1 trial

  19. Liraglutide placebo, Saxenda 6 mg/mL solution for injection in pre-filled pen

    NovoThirteen

    Obesity

    phase 3 small molecule active

    1 trial

  20. Lisdexamfetamine Dimesylate (LDX)

    Takeda

    ADHD

    phase 3 small molecule completed

    3 trials

  21. Lisdexamfetamine dimesylate

    Takeda

    Binge Eating Disorder

    phase 3 small molecule completed

    2 trials

  22. Live Attenuated Respiratory Syncytial Virus (RSV) βˆ†NS2/βˆ†1313/I1314L vaccine, Matched

    Sanofi-aventis Healthcare Pty Ltd

    Virus diseases

    phase 3 small molecule active

    1 trial

  23. Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immunoglobulin Light-chain Amyloidosis

    phase 3 small molecule active

    1 trial

  24. Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation Proctitis

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources